Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
| Revenue: $2.04B |
| Revenue Growth (YOY): 16.88% |
| Profit (% of Rev): 67.41% |
| Income (% of Rev): 27.73% |
| Income Growth (YOY): 35.94% |
| Operating Income: $577M |
| Operating Cash Flow: $706M |
| Operating Cash Flow Growth (YoY): 28.83% |
| Annual Dividend Yield: 0.00% |
| Total Assets: $17.74B |
| Total Liabilities: $2.07B |
| Cash & Equivalent: $2.41B |
| Total Debt: $0M |
| Debt/Equity: 0.04 |
| Quick Ratio: 3.42 |
| Current Ratio: 4.30 |
| Price/Book: 11.22 |
| Price/Earnings: 77.33 |
| EBITDA: $694M |
| EPS: 1.59 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Buy.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.